Revenio Group Oyj

Report Publication Announcement • Apr 26, 2013

Disclosure 306837

Revenio Group Oyj - Company Announcement

Revenio Group Corporation: 1-2Q /2013 INTERIM REPORT RELEASE DATE CHANGES

Revenio Group Corporation Stock Exchange Release, 26th of April 2013, 15:00 hrs REVENIO GROUP'S 1-2Q /2013 INTERIM REPORT RELEASE DATE CHANGES Revenio Group's 1-2q/2013 interim report release date changes. The report will be released on 5th of August 2013. Revenio Group Corporation Olli-Pekka Salovaara President and CEO For further information, please contact: Olli-Pekka Salovaara, President and CEO, GSM +358 (0) 40 567 5520 olli-pekka.salovaara@revenio.fi Http://www.revenio.fi DISTRIBUTION: NASDAQ OMX Helsinki Financial Supervisory Authority (FIN-FSA) Key media www.revenio.fi The Revenio Group in brief Revenio is a Finnish health tech group whose core business is tonometers. The Revenio Health Tech segment comprises the operations of Icare Finland Oy. The widely patented Icare product family is the current cornerstone of the Group's success. Revenio seeks vigorous growth in health technology, both organically and through acquisitions and mergers. The Revenio Group also includes other business operations, which are grouped under the Technology and Services segment. This segment's operations have a shared global market and represent the cutting edge of technology products and services in their industry. These businesses are extremely profitable in their industries and generate positive cash flow. In 2012, the Revenio Group's net sales totaled EUR 25.4 million, with its operating margin standing at 19.4 percent. The Revenio Group Corporation is listed on NASDAQ OMX Helsinki. [HUG#1696909]